Drugs are being invented and manufactured right here in the U.S. by Americans, for Americans. So why doesn’t the industry ...

Conflicts of interest on federal government vaccine panels have declined to “historically low levels” in recent years ...

A New Jersey pharmaceutical company filed a lawsuit in federal court last week challenging a new Maine law aimed to protect a ...

The Trump administration's ever-changing tariffs and Most Favored Nation drug pricing are part of a blizzard of unclear, ...

The announcement by President Donald Trump's administration of the results of a probe into pharmaceutical imports and new ...

An empty reserve undermines national preparedness for health crises like pandemics and bioterrorism where rapid access to ...

The European Union's trade deal with the United States could cost the pharmaceutical industry between $13 billion and $19 billion as branded medicines become subject to a tariff of 15%, analysts said ...

OpenSecrets reports the pharma industry led lobbying in Q2 2025, spending $105.4 million, followed by Ballard Partners at $20 ...

The industry’s reputation surged during the COVID-19 pandemic, according to PatientView’s annual survey of patient groups, peaking two years ago, when 60% of those surveyed said pharma’s ...

The partnership grants Envirotainer exclusive global rights to offer the innovative Swiss Airtainer as part of its full ...

Unlike traditional pharmaceutical companies that own and market their products, CFAO Healthcare South Africa operates as a ...

This partnership offers a preview of the future: smarter containers that integrate renewable energy, digital visibility, and lightweight design into one solution.